Combination of Kaempferol and Docetaxel Induces Autophagy in Prostate Cancer Cells In Vitro and In Vivo

Docetaxel is a first-line chemotherapy drug used to treat advanced prostate cancer, but patients who have used it often face the challenges of drug resistance and side effects. Kaempferol is a naturally occurring flavonol; our previous studies have confirmed that it has excellent anti-prostate activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Qian, Fang, Gang, Pang, Yuzhou, Wang, Xueni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572510/
https://www.ncbi.nlm.nih.gov/pubmed/37833967
http://dx.doi.org/10.3390/ijms241914519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572510/
https://www.ncbi.nlm.nih.gov/pubmed/37833967
http://dx.doi.org/10.3390/ijms241914519

Ejemplares similares